J Telemed Telecare. 2025 Dec 10:1357633X251389690. doi: 10.1177/1357633X251389690. Online ahead of print.ABSTRACTIntroductionTelemedicine has implemented the regional networks between 24/7 catheterization laboratories of "Hub" hospitals and the Territorial Emergency Medical Service (TEMS) to reduce
Heart Fail Rev. 2025 Dec 10;31(1):11. doi: 10.1007/s10741-025-10579-y.ABSTRACTSubcutaneous glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been shown to reduce risk of major adverse cardiac events (MACE) for patients with type 2 diabetes (T2DM) who have or are at high risk of cardiovascul
JMIR Res Protoc. 2025 Dec 10;14:e76871. doi: 10.2196/76871.ABSTRACTBACKGROUND: In the United States, mental health complications and cardiovascular events are the 2 leading causes of death for birthing parents in the year following delivery. Most of these deaths are preventable, with Black and Latin
JAMA Cardiol. 2025 Dec 10. doi: 10.1001/jamacardio.2025.4491. Online ahead of print.ABSTRACTIMPORTANCE: Cardiovascular inflammation is a major determinant of atherosclerotic disease, and inhibition of the central signaling cytokine, interleukin 6 (IL-6), is a promising target for intervention. Patie
Nephrol Dial Transplant. 2025 Dec 10:gfaf260. doi: 10.1093/ndt/gfaf260. Online ahead of print.ABSTRACTBACKGROUND: IgA vasculitis with nephritis (IgAV-N) is characterized by IgA-containing immune complexes deposition. Neutrophilic infiltration is typically observed in skin lesions and may also occur
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251401588. doi: 10.1177/10760296251401588. Epub 2025 Dec 10.ABSTRACTBackgroundThere is conflicting evidence of the correlation between fatty acid binding protein 4 (FABP4) and cardiovascular disease (CVD) in previous observational studies.ObjectiveThi
Clin Rheumatol. 2025 Dec 10. doi: 10.1007/s10067-025-07827-9. Online ahead of print.ABSTRACTBACKGROUND: Current evidence indicates that high serum urate levels are associated with an increased occurrence of atrial fibrillation (AF), and urate-lowering drugs could potentially reduce this risk. Noneth
Am J Clin Dermatol. 2025 Dec 10. doi: 10.1007/s40257-025-00992-2. Online ahead of print.ABSTRACTPsoriasis is a chronic immune-mediated skin condition that is associated with cardiovascular disease, obesity, and other comorbidities. While highly linked to genetics, psoriasis is also significantly imp
Mol Biol Rep. 2025 Dec 10;53(1):172. doi: 10.1007/s11033-025-11242-3.ABSTRACTThe epidermal growth factor receptor (EGFR) is a key regulator of cell proliferation and a well-established therapeutic target in non-small-cell lung cancer (NSCLC). Somatic mutations in the EGFR gene have been widely studi
Cardiovasc Drugs Ther. 2025 Dec 10. doi: 10.1007/s10557-025-07821-y. Online ahead of print.ABSTRACTPURPOSE: Natriuretic peptides (NPs) ANP, BNP, and CNP extend beyond biomarkers of wall stress to regulators of cardiovascular, renal, metabolic, and immune pathways via cGMP-PKG signaling. We synthesiz
Pituitary. 2025 Dec 10;29(1):16. doi: 10.1007/s11102-025-01620-2.ABSTRACTHypertension affects nearly half of patients with acromegaly, yet current studies inconsistently report blood pressure phenotypes due to variability in the use of office, home, and ambulatory monitoring. This companion article
Curr Atheroscler Rep. 2025 Dec 10;27(1):122. doi: 10.1007/s11883-025-01344-5.ABSTRACTPURPOSE OF REVIEW: Most observational studies quantify the relationship between diet, cardiovascular disease (CVD), and environmental impacts independently, resulting in a fragmented understanding of sustainable die
Heart Fail Rev. 2025 Dec 10;31(1):12. doi: 10.1007/s10741-025-10571-6.ABSTRACTIn the last decade, an increasing number of left ventricular assist devices (LVADs) have been implanted to treat patients with end-stage heart failure. Although LVAD therapy improves hemodynamics and survival, it is also a
Int J Clin Pharm. 2025 Dec 10. doi: 10.1007/s11096-025-02065-0. Online ahead of print.ABSTRACTINTRODUCTION: Atherosclerosis is the pathological foundation of most cardiovascular diseases and remains the leading cause of mortality worldwide. Increasing evidence shows that pyroptosis, a pro-inflammato
Am J Physiol Heart Circ Physiol. 2025 Dec 10. doi: 10.1152/ajpheart.00364.2025. Online ahead of print.ABSTRACTMicroRNAs (miRNAs), short non-coding RNAs that post-transcriptionally regulate gene expression, have emerged as critical regulators of cardiac genes. Although circulating miRNAs have been im
J Refract Surg. 2025 Dec;41(12):e1264-e1275. doi: 10.3928/1081597X-20250917-01. Epub 2025 Dec 1.ABSTRACTPURPOSE: To develop a novel intraocular lens (IOL) power calculation formula by predicting the actual lens position (ALP) in patients with Marfan syndrome who have ectopia lentis undergoing IOL im
J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)10005-3. doi: 10.1016/j.jacc.2025.10.036. Online ahead of print.ABSTRACTBACKGROUND: The PCSK9 inhibitor evolocumab decreases the risk of major adverse cardiovascular events (MACE). The relationship between body mass index (BMI) and benefit of evolocumab r
No abstractJ Am Coll Cardiol. 2025 Nov 19:S0735-1097(25)10033-8. doi: 10.1016/j.jacc.2025.10.047. Online ahead of print.NO ABSTRACTPMID:41369618 | DOI:10.1016/j.jacc.2025.10.047
J Am Coll Cardiol. 2025 Nov 8:S0735-1097(25)10065-X. doi: 10.1016/j.jacc.2025.10.054. Online ahead of print.ABSTRACTBACKGROUND: Stabilizers/silencers limit new transthyretin amyloid formation, whereas emerging agents aim to clear existing deposits. Cardiovascular magnetic resonance (CMR) extracellul
No abstractJ Am Acad Dermatol. 2025 Dec 9:S0190-9622(25)03250-5. doi: 10.1016/j.jaad.2025.11.047. Online ahead of print.NO ABSTRACTPMID:41369607 | DOI:10.1016/j.jaad.2025.11.047
JACC Case Rep. 2025 Dec 10:106407. doi: 10.1016/j.jaccas.2025.106407. Online ahead of print.ABSTRACTBACKGROUND: Homozygous familial hypercholesterolemia (HoFH) is challenging to treat, requiring intensive lipid-lowering therapy often with novel therapies like evinacumab (angiopoietin-like 3 (ANGPLT3
Cells. 2025 Dec 2;14(23):1916. doi: 10.3390/cells14231916.ABSTRACTDilated cardiomyopathy is a major cause of heart failure and is one of the most common forms of cardiomyopathy worldwide. Although there has been significant progress in its clinical management, early diagnosis and precise prognosis r
Cells. 2025 Dec 2;14(23):1913. doi: 10.3390/cells14231913.ABSTRACTWhile vascular smooth muscle cell (SMC) plasticity is increasingly recognised as a critical driver of atherosclerosis progression, most mechanistic insights derive from murine models that fail to fully capture the diversity and comple
Cells. 2025 Dec 1;14(23):1903. doi: 10.3390/cells14231903.ABSTRACTWhen blood flow to a part of the myocardial muscle is reduced or blocked, it leads to tissue ischemia in that region. Myocardial infarction (MI) occurs when the ischemic insult is of sufficient duration in time to induce cardiomyocyte
